Patient Guide: A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 20 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06148506
Status: ACTIVE_NOT_RECRUITING
Condition: HR+HER2- Advanced Breast Cancer
Phase: Not Specified

Find a Study Location Near You

This study is available at 20 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Kaluga, Russia
  • Barnaul,
  • Chelyabinsk,
  • • And 17 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily